Michal Kolář

Dr. Michal Kolář

Institute of Molecular Genetics, Czech Academy of Sciences
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2015 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
OKOndrej Kodet
Ondrej Kodet
Lukas LacinaLukas Lacina
Lukas Lacina
EKEliška Krejčí
Eliška Krejčí
BDBarbora Dvorankova
Barbora Dvorankova
MGMiloš Grim
Miloš Grim
Karel SmetanaKarel Smetana
Karel Smetana
Nodular melanoma is one of the most life threatening tumors with still poor therapeutic outcome. Similarly to other tumors, permissive microenvironment is essential for melanoma progression. Features of this microenvironment are arising from molecular crosstalk between the melanoma cells (MC) and the surrounding cell populations in the context of skin tissue. Here, we study the effect of melanoma cells on human primary keratinocytes (HPK). Presence of MC is as an important modulator of the tumor microenvironment and we compare it to the effect of nonmalignant lowly differentiated cells also originating from neural crest (NCSC).

21 November 2022 in Cells
Verified
Journal Article
Open access
PDF file
MRMagdalena Rašková
Magdalena Rašková
Lukas LacinaLukas Lacina
Lukas Lacina
Zdenek KejikZdenek Kejik
Zdenek Kejik
AVAnna Venhauerová
Anna Venhauerová
MSMarkéta Skaličková
Markéta Skaličková
JBJan Brábek
Jan Brábek
Interleukin 6 (IL-6) belongs to a broad class of cytokines involved in the regulation of various homeostatic and pathological processes. These activities range from regulating embryonic development, wound healing and ageing, inflammation, and immunity, including COVID-19. In this review, we summarise the role of IL-6 signalling pathways in cancer biology, with particular emphasis on cancer cell invasiveness and metastasis formation. Targeting principal components of IL-6 signalling (e.g., IL-6Rs, gp130, STAT3, NF-κB) is an intensively studied approach in preclinical cancer research. It is of significant translational potential; numerous studies strongly imply the remarkable potential of IL-6 signalling inhibitors, especially in metastasis suppression.

20 May 2020 in Journal of Cheminformatics
Verified
Journal Article
Open access
PDF file
MVMilan Voršilák
Milan Voršilák
Michal KolářMichal Kolář
Michal Kolář
IČIvan Čmelo
Ivan Čmelo
DSDaniel Svozil
Daniel Svozil
SYBA (SYnthetic Bayesian Accessibility) is a fragment-based method for the rapid classification of organic compounds as easy- (ES) or hard-to-synthesize (HS). It is based on a Bernoulli naïve Bayes classifier that is used to assign SYBA score contributions to individual fragments based on their frequencies in the database of ES and HS molecules. SYBA was trained on ES molecules available in the ZINC15 database and on HS molecules generated by the Nonpher methodology. SYBA was compared with a random forest, that was utilized as a baseline method, as well as with other two methods for synthetic accessibility assessment: SAScore and SCScore. When used with their suggested thresholds, SYBA improves over random forest classification, albeit marginally, and outperforms SAScore and SCScore. However, upon the optimization of SAScore threshold (that changes from 6.0 to – 4.5), SAScore yields similar results as SYBA. Because SYBA is based merely on fragment contributions, it can be used for the analysis of the contribution of individual molecular parts to compound synthetic accessibility. SYBA is publicly available athttps://github.com/lich-uct/sybaunder the GNU General Public License.

20 July 2016 in Cancers
Verified
Journal Article
Open access
PDF file
DHDusan Hrckulak
Dusan Hrckulak
Michal KolářMichal Kolář
Michal Kolář
HSHynek Strnad
Hynek Strnad
VKVladimir Korinek
Vladimir Korinek
T-cell factor/lymphoid enhancer-binding factor (TCF/LEF) proteins (TCFs) from the High Mobility Group (HMG) box family act as the main downstream effectors of the Wnt signaling pathway. The mammalian TCF/LEF family comprises four nuclear factors designated TCF7, LEF1, TCF7L1, and TCF7L2 (also known as TCF1, LEF1, TCF3, and TCF4, respectively). The proteins display common structural features and are often expressed in overlapping patterns implying their redundancy. Such redundancy was indeed observed in gene targeting studies; however, individual family members also exhibit unique features that are not recapitulated by the related proteins. In the present viewpoint, we summarized our current knowledge about the specific features of individual TCFs, namely structural-functional studies, posttranslational modifications, interacting partners, and phenotypes obtained upon gene targeting in the mouse. In addition, we employed several publicly available databases and web tools to evaluate the expression patterns and production of gene-specific isoforms of the TCF/LEF family members in human cells and tissues.

1 March 2014 in Annals of Hepatology
Verified
Journal Article
Open access
RKRenata Koníčková
Renata Koníčková
KVKaterina Hadrava Vanova
Katerina Hadrava Vanova
JVJana Vaníková
Jana Vaníková
LMLucie Muchova
Lucie Muchova
ISIva Subhanová
Iva Subhanová
Libor VitekLibor Vitek
Libor Vitek
Spirulina platensis is a blue-green alga used as a dietary supplement because of its hypocholesterolemic properties. Among other bioactive substances, it is also rich in tetrapyrrolic compounds closely related to bilirubin molecule, a potent antioxidant and anti-proliferative agent. The aim of our study was to evaluate possible anticancer effects of S. platensis and S. platensis-derived tetrapyrroles using an experimental model of pancreatic cancer. The anti-proliferative effects of S. platensis and its tetrapyrrolic components [phycocyanobilin (PCB) and chlorophyllin, a surrogate molecule for chlorophyll A] were tested on several human pancreatic cancer cell lines and xenotransplanted nude mice. The effects of experimental therapeutics on mitochondrial reactive oxygen species (ROS) production and glutathione redox status were also evaluated. Compared to untreated cells, experimental therapeutics significantly decreased proliferation of human pancreatic cancer cell lines in vitro in a dose-dependent manner (from 0.16 g•L-1 [S. platensis], 60 μM [PCB], and 125 μM [chlorophyllin], p<0.05). The anti-proliferative effects of S. platensis were also shown in vivo, where inhibition of pancreatic cancer growth was evidenced since the third day of treatment (p < 0.05). All tested compounds decreased generation of mitochondrial ROS and glutathione redox status (p = 0.0006; 0.016; and 0.006 for S. platensis, PCB, and chlorophyllin, respectively). In conclusion, S. platensis and its tetrapyrrolic components substantially decreased the proliferation of experimental pancreatic cancer. These data support a chemopreventive role of this edible alga. Furthermore, it seems that dietary supplementation with this alga might enhance systemic pool of tetrapyrroles, known to be higher in subjects with Gilbert syndrome.

1 February 2013 in Gastroenterology
Verified
Journal Article
Closed access
BFBohumil Fafilek
Bohumil Fafilek
MKMichaela Krausova
Michaela Krausova
MVMartina Vojtechova
Martina Vojtechova
VPVendula Pospichalova
Vendula Pospichalova
LTLucie Tumova
Lucie Tumova
VKVladimir Korinek
Vladimir Korinek